Literature DB >> 17338959

The syndrome of rhabdomyolysis: Pathophysiology and diagnosis.

George D Giannoglou1, Yiannis S Chatzizisis, Gesthimani Misirli.   

Abstract

Rhabdomyolysis is defined as a pathological condition of skeletal muscle cell damage leading to the release of toxic intracellular material into the blood circulation. Its major causes include trauma, ischemia, drugs, toxins, metabolic disorders, and infections. The pathophysiological hallmark of the syndrome is an increase in intracellular free ionized calcium due to either cellular energy depletion, or direct plasma membrane rupture. The increased intracellular calcium activates several proteases, intensifies skeletal muscle cell contractility, induces mitochondrial dysfunction, and increases the production of reactive oxygen species, ultimately resulting in skeletal muscle cell death. Clinically, the syndrome presents with severe muscular pain, weakness and myoglobinuria. Increased myoglobin and creatine phosphokinase as a consequence of muscular cell death are the major laboratory findings, which, in combination with the clinical presentation, lead the clinician to the final diagnosis of the syndrome.

Entities:  

Year:  2007        PMID: 17338959     DOI: 10.1016/j.ejim.2006.09.020

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  64 in total

1.  Viral lateral pterygoid rhabdomyolysis presenting as trismus.

Authors:  Mona Thakre
Journal:  J Neurol       Date:  2016-04-19       Impact factor: 4.849

Review 2.  A "crush" course on rhabdomyolysis: risk stratification and clinical management update for the perioperative clinician.

Authors:  Devan R Cote; Eva Fuentes; Ali H Elsayes; Jonathan J Ross; Sadeq A Quraishi
Journal:  J Anesth       Date:  2020-05-18       Impact factor: 2.078

3.  Bone scintigraphy of severe hypercalcemia following simvastatin induced rhabdomyolysis.

Authors:  Zubair B Mirza; Sophia Hu; Louis F Amorosa
Journal:  Clin Cases Miner Bone Metab       Date:  2017-02-10

4.  Severe asymptomatic rhabdomyolysis complicating a mycoplasma pneumonia.

Authors:  Alex Gosselt; Jobien Olijhoek; Thomas Wierema
Journal:  BMJ Case Rep       Date:  2017-07-26

Review 5.  Risk factors and drug interactions predisposing to statin-induced myopathy: implications for risk assessment, prevention and treatment.

Authors:  Yiannis S Chatzizisis; Konstantinos C Koskinas; Gesthimani Misirli; Christos Vaklavas; Apostolos Hatzitolios; George D Giannoglou
Journal:  Drug Saf       Date:  2010-03-01       Impact factor: 5.606

6.  Recurrent myoglobinuria in a sporadic patient with a novel mitochondrial DNA tRNA(Ile) mutation.

Authors:  Valentina Emmanuele; Evangelia Sotiriou; Maryam Shirazi; Kurenai Tanji; Ronald G Haller; Katja Heinicke; Peter E Bosch; Michio Hirano; Salvatore DiMauro
Journal:  J Neurol Sci       Date:  2011-02-15       Impact factor: 3.181

7.  Acute renal failure due to rhabdomyolysis after proximal humerus fracture associated with axillary artery rupture.

Authors:  G Mouzopoulos; N Lasanianos; D Mouzopoulos; G Batanis; M Tzurbakis; I Georgilas
Journal:  Int Urol Nephrol       Date:  2008-06-28       Impact factor: 2.370

Review 8.  Antipsychotic-induced elevation of creatine kinase: a systematic review of the literature and recommendations for the clinical practice.

Authors:  Zacharias G Laoutidis; Kanellos T Kioulos
Journal:  Psychopharmacology (Berl)       Date:  2014-10-16       Impact factor: 4.530

9.  Hypertensive Crisis with Neurological Impairment Mimicking a Guillain-Barrè Syndrome: Searching for a Link.

Authors:  Alberto Mazza; Marta Lucchetta; Gioia Torin; Laura Schiavon; Antonella Paola Sacco; Giorgio Villi; Michela Armigliato; Edoardo Casiglia
Journal:  High Blood Press Cardiovasc Prev       Date:  2018-10-08

10.  Spinning-induced Rhabdomyolysis: Eleven Case Reports and Review of the Literature.

Authors:  Daejin Kim; Eun-Jung Ko; HyeJeong Cho; Su Hyung Park; Sang Hwan Lee; Nam-Gil Cho; So-Young Lee; Hye Yun Jeong; Dong Ho Yang
Journal:  Electrolyte Blood Press       Date:  2015-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.